SUL-DUR With Meropenem Synergistic Against CRAB Isolates

A new study found Xacduro (Innoviva) and meropenem was synergistic in a carbapenem-resistant CRAB isolate.

AUGUST 4, 2025

Better Tools for Fighting Gram-Negative Infections, but More Are Needed

Multidrug-resistant gram-negative bacteria are difficult to treat, but FDA approvals have increased the clinical ...

FEBRUARY 27, 2025

Cefiderocol May Be Game Changer for Acinetobacter

Cefiderocol may be a game changer for treating resistant Acinetobacter in patients with limited or no alternative ...

FEBRUARY 21, 2025

New Dual Antibiotic Approval Fills Major Gap in Treating Resistant A. baumannii

The antibiotic combination sulbactam-durlobactam was approved to treat hospital-acquired and ventilator-associated ...

MARCH 6, 2024

New Dual Antibiotic Approval Fills Major Gap in Treating Resistant A. baumannii

A. baumannii caused an estimated 8,500 infections in hospitalized patients and 700 deaths in the United ...

NOVEMBER 22, 2023

Xerava Shows Promise For Treating CRAB

Combination therapy with eravacycline shows favorable clinical and microbiological outcomes among patients with ...

OCTOBER 24, 2022

Just a Little Crabby: CRAB Risk Low, Tied to Health Care Facilities

Incidence rates of carbapenem-nonsusceptible Acinetobacter baumannii in the United States are quite low, with ...

MARCH 21, 2018